Market Movers | Winners: RPC, COCH, RENX | Losers: LIMN, UPB, OBAI
On Wednesday, February 11, markets were split, as the S&P 500 remaining flat, the Dow 30 falling 0.13%, and the Nasdaq 100 rising 0.29% moved in different directions. Similar variation was seen across individual stocks.
List of Market Winners
The following table shows the list of 10 stocks that generated the highest returns on the last trading day:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | RPC | Ridgepost Capital | 5289900.0% | 5289900.0% |
| 2 | COCH | Envoy Medical | 69.2% | -0.2% |
| 3 | RENX | RenX Enterprises | 51.6% | 11.7% |
| 4 | SUNE | SUNation Energy | 42.3% | 105.8% |
| 5 | MNTN | MNTN | 37.1% | -6.6% |
| 6 | SIF | SIFCO Industries | 35.7% | 58.6% |
| 7 | TDC | Teradata | 29.6% | 24.4% |
| 8 | DIOD | Diodes | 26.4% | 58.1% |
| 9 | AEHR | Aehr Test Systems | 26.2% | 67.7% |
| 10 | VRT | Vertiv | 24.5% | 53.4% |
List of Market Losers
- Does Alphabet Stock Still Have Room to Run?
- How Advanced Micro Devices Stock Gained 90%
- How To Earn 13% Yield While Waiting to Buy APH 30% Cheaper
- Cash Machine Trading Cheap – Adobe Stock Set to Run?
- Walmart Stock Hands $76 Bil Back – Worth a Look?
- UnitedHealth Stock Shares $77 Bil Success With Investors
On the other hand, the following table shows the list of 10 stocks that generated the lowest returns:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | LIMN | Liminatus Pharma | -52.6% | -2.1% |
| 2 | UPB | Upstream Bio | -47.2% | -45.9% |
| 3 | OBAI | TG-17 | -44.6% | -79.8% |
| 4 | AREB | American Rebel | -39.0% | -95.6% |
| 5 | BRTX | BioRestorative Therapies | -35.4% | -64.9% |
| 6 | RPD | Rapid7 | -29.0% | -51.4% |
| 7 | SSII | SS Innovations International | -26.7% | -41.5% |
| 8 | DBGI | Digital Brands | -26.7% | -74.8% |
| 9 | U | Unity Software | -26.3% | -51.5% |
| 10 | VHUB | Venhub Global | -25.6% | -59.2% |
Why does this matter? Significant stock moves – up or down – deserve your attention. Sharp declines in fundamentally strong names can offer smart buying opportunities. And when momentum aligns with solid fundamentals, riding the trend can be highly rewarding.
Individual stocks can soar or tank, but one thing matters: staying invested. The Trefis High Quality Portfolio helps you do that.
Movers – Last One Week
Analysing over the last one week (5 trading days), markets rallied broadly, with the S&P 500 rising 0.85%, the Dow 30 rising 1.25%, and the Nasdaq 100 rising 1.25%. While many stocks participated in the rally, some lagged behind.
List of 1-Week Market Winners
The following table shows the list of 10 stocks that generated the highest returns over the last week:
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | RPC | Ridgepost Capital | 5289900.0% | 5289900.0% |
| 2 | PFSA | Profusa | 3314.6% | -62.6% |
| 3 | HCTI | Healthcare Triangle | 3302.1% | -79.1% |
| 4 | ATPC | Agape ATP | 2888.1% | -52.9% |
| 5 | UGRO | Urban-gro | 2406.8% | -47.7% |
| 6 | ADIL | Adial Pharmaceuticals | 1717.6% | -48.2% |
| 7 | ASST | Strive | 1265.6% | -45.2% |
| 8 | BEBE | TGE Value Creative Solutions | 1157.9% | 1157.9% |
| 9 | RLYB | Rallybio | 727.5% | -13.3% |
| 10 | FCUV | Focus Universal | 705.1% | -33.7% |
List of 1-Week Market Losers
Similarly, the following table shows the 10 stocks that were at the bottom in terms of returns:
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | PLYX | Polaryx Therapeutics | -83.9% | -89.7% |
| 2 | OBAI | TG-17 | -79.8% | -79.8% |
| 3 | QVCGA | QVC | -67.4% | -67.4% |
| 4 | ERNA | Ernexa Therapeutics | -64.4% | -74.8% |
| 5 | DBGI | Digital Brands | -60.0% | -74.8% |
| 6 | BRTX | BioRestorative Therapies | -59.9% | -64.9% |
| 7 | VHUB | Venhub Global | -59.3% | -59.2% |
| 8 | LIMN | Liminatus Pharma | -58.2% | -2.1% |
| 9 | IVDA | Iveda Solutions | -54.0% | -69.3% |
| 10 | EAF | GrafTech International | -53.8% | -51.1% |
Movers – Last One Month
On a slightly wider timeline over the last one month, index performance was mixed — the S&P 500 falling 0.51%, the Dow 30 rising 1.07%, and the Nasdaq 100 falling 2.27% offered no clear consensus. Stock-specific factors shaped outcomes throughout the market.
List of 1-Month Market Winners
The following table shows the 10 stocks that generated the maximum returns over the last one month:
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | RPC | Ridgepost Capital | 5289900.0% | 5289900.0% |
| 2 | VMAR | Vision Marine Technologies | 1727.4% | -66.1% |
| 3 | ASBP | Aspire Biopharma | 1321.1% | -74.4% |
| 4 | BEBE | TGE Value Creative Solutions | 1157.9% | 1157.9% |
| 5 | LIFE | Ethos Technologies | 1150.3% | 1150.3% |
| 6 | DSAC | Daedalus Special Acquisition | 539.1% | 578.2% |
| 7 | BNAI | Brand Engagement Network | 433.6% | 659.1% |
| 8 | GITS | Global Interactive Technologies | 237.5% | 277.4% |
| 9 | CRVS | Corvus Pharmaceuticals | 192.4% | 156.4% |
| 10 | IBRX | ImmunityBio | 152.5% | 230.3% |
List of 1-Month Market Losers
In the same period, these 10 stocks were at the bottom in terms of returns:
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | AREB | American Rebel | -95.3% | -95.6% |
| 2 | NBY | NovaBay Pharmaceuticals | -95.1% | -88.3% |
| 3 | PBM | Psyence Biomedical | -90.5% | -89.9% |
| 4 | CALC | CalciMedica | -87.1% | -89.4% |
| 5 | LRHC | La Rosa | -82.3% | -79.0% |
| 6 | MTVA | MetaVia | -79.7% | -80.3% |
| 7 | QNCX | Quince Therapeutics | -79.3% | -81.8% |
| 8 | LHAI | Linkhome | -78.9% | -81.5% |
| 9 | DBGI | Digital Brands | -78.5% | -74.8% |
| 10 | GUTS | Fractyl Health | -78.3% | -80.3% |
Picking winners on a consistent basis is not an easy task – especially given the volatility associated with a single stock. Instead, the Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.